News

  • NN106 Cyto-C Clinical Trial Prospective Biomarker Study Results Published

    NN106 CYTO-C Prospective biomarker study results have been published in Neurooncology Advances.  

  • NN103 (BeatMG) Study Results Cited in NeurologyLive

    Results of the NN103 study were cited in NeurologyLive.  

  • NN103 Primary Results published in Neurology

    The results of the NN103 Beat MG have been posted online at the American Academy of Neurology.  

  • Dixie Ecklund named to Society for Clinical Trials Class of 2021 Fellows

    Congratulations to Dixie Ecklund, Director of Operations at the NeuroNEXT DCC, for being selected to join the Society for Clinical Trials Class of 2021 Fellows! Ecklund will be recognized as a new inductee at the virtual SCT annual meeting in May.

  • NeuroNEXT Fellow and CTMC Alum highlighted at Wake Forest CTSI

    A NeuroNEXT Fellowship can help young neurology faculty develop their careers, as highlighted by Wake Forest University in an article about former NeuroNEXT Fellow and Clinical Trials Methodology Course (CTMC) alumnus Dr. Heidi Munger Clay (see link below).

  • CTMC: 2021 Call for Applications

    We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2021 cohort. The overarching goal of the CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. Our focus is on investigators who have not previously designed their own prospective, interventional clinical trials.    Course:  Due to…

  • NeuroNEXT 2020 Annual Meeting

    NeuroNEXT Leadership would like to thank everyone for another successful annual meeting! We were able to celebrate several milestones in our virtual format, including: 

  • Update: Clinical Trials Methodology Course 2020

    A message from the Executive Committee of the Clinical Trials Methodology Course (CTMC):  Due to the global COVID-19 (Coronavirus) pandemic and the number of uncertainties that accompany such a health crisis, the Clinical Trials Methodology Course (CTMC) Executive Committee has decided to postpone the Course until next year. The Executive Committee would like to thank…

  • NeuroNEXT Response to COVID 19

    A message from Merit Cudkowicz and Christopher Coffey, March 18, 2020:  Dear NeuroNEXT PIs and Coordinators,  We would like to share some updates regarding NeuroNEXT Network response to the evolving COVID-19 crisis.  As you all know, the COVID-19 situation and response is evolving rapidly.  There has already been and will likely continue to be significant…

  • Joyce Moran elected Fellow of the ACRP

    The Association of Clinical Research Professionals (ACRP) has selected NeuroNEXT Project Manager Joyce Moran from our Columbia University Medical Center and Weill Cornell Medical College clinical sites to become a Fellow of the ACRP (FACRP). This FACRP designation represents a global mark of distinction for Joyce; each year, only a handful of clinical research professionals are selected worldwide! This…